secwatch.observer — SEC 8-K summary
======================================

Issuer:     Spectral AI, Inc. (MDAI)
CIK:        0001833498
Form:       8-K
Filed at:   2023-06-22T23:59:59+00:00
Accession:  0001213900-23-050967
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rosecliff Acquisition Corp I furnishes investor presentation for proposed Spectral MD business combination
--------------------------------------------------------------------------------

- DeepView System received FDA Breakthrough Device Designation for burn indication in 2018.
- Spectral MD has secured over $130 million in U.S. government contracts for burn and DFU development.
- Initial target markets (burn wounds + diabetic foot ulcers) estimated at ~$14.7 billion by 2028.
- Proprietary AI database contains more than 263 billion clinically validated data points.
- Regulatory submissions (FDA, CE, UKCA) expected to commence in 2023 based on positive study outcomes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1833498/000121390023050967/0001213900-23-050967-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1833498/000121390023050967/ea180775-8k425_rosecliff.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-050967

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer